Journal Name: Journal of Hepatology
Journal Type: Q1
ISSN: 01688278, 16000641
Country: Netherlands
Subject Area and Category: Medicine Hepatology
Publisher: Elsevier B.V.
Research Ranking: 31
Publication Type: Journals
H-Index: 319
Coverage: 1985-2025
Editors-in-Chief: Rossana Mirabella , Jonel Trebicka , Jean-Charles Nault , Annalisa Berzigotti , Rita Golfieri , Maxime Ronot , Julie K. Heimbach , Waj Mehal , Christine Sempoux , Anna Chiara Frigo , Sara Montagnese , Jesus Banales , Michael Lucey , Michael Heneghan , Aldo J. Montano-Loza , William Bernal , Thierry Gustot , Wim Laleman , Mattias Mandorfer , Sebastian Marciano , Aleksander Krag , Pierre Nahon , Lorenza Rimassa , Tatiana Kisseleva , Thierry Tordjmann , Holger Willenbring , Martina Gambato , Jérôme Boursier , Jordi Rimola , Guruprasad Aithal , Helena Cortez-Pinto , Henning Grønbæk , Phillip Newsome , Jörn Schattenberg , Dina Tiniakos , Pietro Vajro , Jeremie Guedj , Pietro Lampertico , Bruno Sangro , Bernd Schnabl , Barbara Rehermann , Massimo Pinzani , Quentin M. Anstee , Elisabetta Bugianesi , Raphaël Porcher , Markus Cornberg , Alexander Ploss , José C. Fernández-Checa , Mathias Heikenwalder , Detlef Schuppan , Ulrich Beuers , Gideon M. Hirschfield , Juan G. Abraldes , Pere Ginès , Josep M. Llovet , Vincenzo Mazzaferro , Richard L. Ehman , Rohit Loomba , Valérie Paradis , Jason Grebely , Darius Moradpour , Thomas Pietschmann , Robert Thimme , Fabien Zoulim , Jonel Trebicka
Research Impact Score: 35.1
Impact Factor: 26.8
SCIMAGO SJR: 10.575
APC Cost: $ 5,500
Homepage: https://www.journal-of-hepatology.eu/
Submission Link: https://www.journals.elsevier.com/journal-of-hepatology
Contact Email: jhepatology@easloffice.eu
Address: 364 Indian Boundary Road, Suite A Chesterton, IN 46304, USA.
Overview
The Journal of Hepatology is one of the most respected and authoritative publications in the field of liver disease research. As the official journal of the European Association for the Study of the Liver (EASL), it plays a central role in advancing the understanding, prevention, and treatment of liver conditions worldwide. Researchers, clinicians, and medical professionals turn to this hepatology journal for its high-impact studies and evidence-based insights.
What is the Journal of Hepatology?
The Journal of Hepatology is a peer-reviewed, monthly medical journal that covers all aspects of hepatology — the study of liver diseases. Since its inception in 1985, it has grown to become a top-tier journal that publishes cutting-edge research, reviews, editorials, and clinical guidelines related to liver health and disease. It is indexed in major databases like PubMed, Scopus, and Web of Science and boasts a high impact factor, reflecting its significant influence in the medical community.
Scope and Topics Covered
This leading hepatology journal covers a broad range of topics, including but not limited to:
-
Hepatitis (A, B, C, and E)
-
Cirrhosis and liver fibrosis
-
Liver cancer (Hepatocellular carcinoma)
-
Non-alcoholic fatty liver disease (NAFLD)
-
Alcohol-related liver disease
-
Liver transplantation
-
Viral hepatitis and immunology
-
Metabolic liver disorders
The Journal of Hepatology aims to foster a deeper understanding of liver function and pathology, contributing to better diagnostic tools, therapeutic strategies, and clinical outcomes.
Who Should Read the Journal?
The Journal of Hepatology is essential reading for hepatologists, gastroenterologists, transplant surgeons, researchers, and healthcare professionals involved in liver care. It’s also a valuable resource for medical students, public health experts, and pharmaceutical researchers who are involved in drug development for liver diseases.
Importance in Global Hepatology Research
With liver diseases ranking among the top causes of death globally, the Journal of Hepatology serves as a vital platform for the international scientific community. It bridges the gap between laboratory findings and clinical application, promoting innovation in both basic and clinical hepatology. As liver conditions continue to rise globally, especially in developing countries, the research published in this journal supports evidence-based decision-making for patient care and health policy.
About
The Journal of Hepatology is a premier peer-reviewed medical journal dedicated to advancing the science and clinical practice of hepatology—the study of liver, gallbladder, biliary tree, and pancreas disorders. Published by Elsevier on behalf of the European Association for the Study of the Liver (EASL), the journal has earned global recognition for its high-impact research and authoritative reviews. It stands as a trusted resource for hepatologists, gastroenterologists, researchers, and healthcare professionals worldwide.
A High-Impact Journal with Global Reach
Established in 1985, the Journal of Hepatology has grown into one of the most respected publications in liver-related medical research. With an impressive impact factor—consistently ranking among the top journals in gastroenterology and hepatology—it attracts cutting-edge studies and insightful commentaries. The journal’s rigorous peer-review process ensures that only the highest-quality scientific content is published.
As a leading source for the latest developments in liver research, the journal covers a broad spectrum of topics, including liver cirrhosis, hepatitis, fatty liver disease (NAFLD/NASH), liver cancer, liver transplantation, and more. Each issue features original research articles, clinical trials, meta-analyses, reviews, and expert opinion pieces that contribute to better understanding and treatment of liver diseases.
Why the Journal of Hepatology Stands Out
One of the core strengths of the Journal of Hepatology is its commitment to scientific integrity and clinical relevance. The journal serves as a platform for both basic and translational research, bridging the gap between laboratory discoveries and clinical application. It provides valuable insights for academics, clinicians, and policy-makers alike.
Moreover, the journal is supported by EASL’s mission to promote liver health and foster international collaboration in the field of hepatology. With its global editorial board composed of leading experts, the Journal of Hepatology offers a truly international perspective on liver disease management.
Key Features:
-
Peer-Reviewed Excellence: All submissions undergo a meticulous review process, ensuring scientific accuracy and clinical relevance.
-
Open Access Options: Authors can choose to make their articles available to a wider audience through open-access publishing.
-
Latest Clinical Guidelines: The journal often features updated EASL guidelines and consensus statements, making it a go-to reference for hepatology practices.
-
Cutting-Edge Research: Topics range from viral hepatitis to liver transplantation and hepatocellular carcinoma, keeping readers informed of the latest advances.
Scope
The Journal of Hepatology is a leading peer-reviewed publication dedicated to the field of hepatology, offering a comprehensive platform for the latest scientific research, clinical studies, and innovations related to liver health. As the official journal of the European Association for the Study of the Liver (EASL), it plays a crucial role in advancing knowledge and understanding of liver diseases, their diagnosis, treatment, and prevention.
A Comprehensive Platform for Hepatology Research
The scope of the Journal of Hepatology is broad, covering all aspects of liver disease, including but not limited to:
-
Hepatitis (A, B, C, D, and E)
-
Cirrhosis and liver fibrosis
-
Non-alcoholic fatty liver disease (NAFLD)
-
Alcohol-related liver disease
-
Liver transplantation
-
Hepatocellular carcinoma (HCC)
-
Cholestatic and autoimmune liver diseases
-
Pediatric liver diseases
By embracing both clinical and basic research, the journal ensures that readers—from clinicians to researchers—stay updated on cutting-edge developments in hepatology.
Bridging Basic Science and Clinical Practice
One of the defining features of the Journal of Hepatology is its commitment to integrating basic scientific discoveries with clinical applications. It encourages the submission of translational research that bridges the gap between laboratory findings and patient care. Studies involving molecular biology, genetics, immunology, pharmacology, and epidemiology that contribute to the understanding of liver function and disease progression are highly welcomed.
Peer-Reviewed, High-Impact Publications
All submissions to the Journal of Hepatology undergo a rigorous peer-review process to ensure the highest standards of scientific integrity and relevance. The journal publishes a variety of article types, including:
-
Original research articles
-
Reviews and meta-analyses
-
Clinical trial reports
-
Case studies
-
Editorials and expert opinions
These articles contribute significantly to global hepatology literature and often influence clinical guidelines and treatment protocols.
Global Reach and Accessibility
With an international readership and contributors from all over the world, the Journal of Hepatology fosters global collaboration in liver disease research. Its high impact factor and wide indexing make it a preferred source of information for healthcare professionals, academicians, and students specializing in hepatology and gastroenterology.
A Trusted Resource for Liver Specialists
Whether you’re a hepatologist, gastroenterologist, researcher, or medical student, the Journal of Hepatology serves as a reliable resource to stay informed about the latest trends, therapies, and innovations in liver care. It is also instrumental for those involved in policy-making, public health, and pharmaceutical development related to liver disease.